Gene · 1373
Papers2,057
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,057
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of green light-emitting diode irradiation on hepatic differentiation of hepatocyte-like cells generated from human adipose-derived mesenchymal cells. | Sci Rep | 2023 | 37968291 | PubTator, text mining | PubMed |
| Microbiology and Biochemistry of Pesticides Biodegradation. | Int J Mol Sci | 2023 | 37958952 | PubTator, text mining | PubMed |
| Identification of a prognostic evaluator from glutamine metabolic heterogeneity studies within and between tissues in hepatocellular carcinoma. | Front Pharmacol | 2023 | 37954858 | PubTator, text mining | PubMed |
| Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms. | J Exp Clin Cancer Res | 2023 | 37951921 | PubTator, text mining | PubMed |
| Ino2, activator of yeast phospholipid biosynthetic genes, interacts with basal transcription factors TFIIA and Bdf1. | Curr Genet | 2023 | 37947853 | PubTator, text mining | PubMed |
| A robust six-gene prognostic signature based on two prognostic subtypes constructed by chromatin regulators is correlated with immunological features and therapeutic response in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37938151 | PubTator, text mining | PubMed |
| Partial N-acetyl glutamate synthase deficiency presenting as postpartum hyperammonemia: Diagnosis and subsequent pregnancy management. | JIMD Rep | 2023 | 37927481 | PubTator, text mining | PubMed |
| The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery. | Metabolites | 2023 | 37887384 | PubTator, text mining | PubMed |
| Functional enrichment analysis of mutated genes in children with hyperthyroidism. | Front Endocrinol (Lausanne) | 2023 | 37876543 | PubTator, text mining | PubMed |
| Hunting for the elusive target antigen in gestational alloimmune liver disease (GALD). | PLoS One | 2023 | 37862305 | PubTator, text mining | PubMed |
| Lnc-PKNOX1-1 inhibits tumor progression in cutaneous malignant melanoma by regulating NF-κB/IL-8 axis. | Carcinogenesis | 2023 | 37843471 | PubTator, text mining | PubMed |
| The Physiological and Pathological Role of Acyl-CoA Oxidation. | Int J Mol Sci | 2023 | 37834305 | PubTator, text mining | PubMed |
| Astrocytes in human central nervous system diseases: a frontier for new therapies. | Signal Transduct Target Ther | 2023 | 37828019 | PubTator, text mining | PubMed |
| Synthesis, thermophysical characterization and thermal performance analysis of novel Cu-MXene hybrid nanofluids for efficient coolant applications. | RSC Adv | 2023 | 37818262 | PubTator, text mining | PubMed |
| Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms. | Breast Cancer Res | 2023 | 37817263 | PubTator, text mining | PubMed |
| Arginine reprograms metabolism in liver cancer via RBM39. | Cell | 2023 | 37804830 | PubTator, text mining | PubMed |
| Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation. | Front Immunol | 2023 | 37799714 | PubTator, text mining | PubMed |
| Comparative study of the mechanism of natural compounds with similar structures using docking and transcriptome data for improving in silico herbal medicine experimentations. | Brief Bioinform | 2023 | 37798251 | PubTator, text mining | PubMed |
| Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives. | Biomolecules | 2023 | 37759686 | PubTator, text mining | PubMed |
| Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma. | Cells | 2023 | 37759483 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1373/papers?page=10